diseases, including scrapie and bovine spongiform encephalopathy of animals and Creutzfeldt-Jakob and Gerstmann-Straussler-Scheinker diseases of humans. Infectious prion particles are composed largely, if not entirely, of an abnormal isoform of the prion protein, which is encoded by a chromosomal gene. A posttranslational process, as yet unidentified, converts the cellular prion protein into an abnormal isoform. Scrapie incubation times, neuropathology, and prion synthesis in transgenic mice are controlled by the prion protein gene. Point mutations in the prion protein genes of animals and humans are genetically linked to development of neurodegeneration. Transgenic mice expressing mutant prion proteins spontaneously develop neurologic dysfunction and spongiform neuropathology. Understanding prion diseases may advance investigations of other neurodegenerative disorders and of the processes by which neurons differentiate, function for decades, and then grow senescent.
pRIONS ARE INFECTIOUS PATHOGENS THAT DIFFER FROM bacteria, fungi, parasites, viroids, and viruses, both with respect to their structure and with respect to the diseases that they cause (1) . Molecular biological and structural studies of prions promise to open new vistas into fundamental mechanisms of cellular regulation and homeostasis not previously appreciated. Kuru, Creutzfeldt-Jakob disease (CJD), and Gerstmann-StrausslerScheinker syndrome (GSS,) are all human neurodegenerative diseases that are caused by prions and are frequently transmissible to laboratory animals (2) . Familial CJD and GSS are also genetic disorders. Individuals at risk can often be identified decades in advance of central nervous system (CNS) dysfunction (3, 4) , yet no effective therapy exists to prevent these lethal disorders.
In addition to the three prion diseases of humans, four disorders of animals are included in the ensemble of prion diseases. Scrapie of sheep and goats is the most studied of the prion diseases. Bovine spongiform encephalopathy (BSE), transmissible mink encephalopathy, and chronic wasting disease of captive mule deer and elk are all thought to result from the ingestion of scrapie-infected animal products. BSE threatens the beef industry of Great Britain (5) and possibly other countries; the production of pharmaceuticals (6) involving cattle is also of concern. Control of sheep scrapie in many countries is a persistent and vexing problem (7) .
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Since 1986, more than 28,500 cattle have died of BSE in Great Britain (5) . Many investigators contend that BSE, often referred to as "mad cow disease," resulted from the feeding of dietary protein supplements derived from rendered sheep offal infected with scrapie to cattle, a practice banned since 1988 (5) . It is thought that BSE will disappear with the cessation of feeding rendered meat and bone meal, as has been the case in kuru of humans, confined to the Fore region of New Guinea and once the most common cause of death among women and children. Kuru has almost disappeared with the cessation of ritualistic cannibalism, suggesting that kuru was transmitted orally, as proposed for BSE.
The Prion Hypothesis
The unusual biological properties of the scrapie agent were first recognized in studies with sheep (8) . The experimental transmission of scrapie to mice (9) gave investigators a convenient laboratory model that provided information on the nature of the unusual infectious pathogen that causes scrapie (10, 11) . Yet progress was slow because quantitation of infectivity in a single sample required housing 60 mice for 1 year before accurate scoring could be accomplished (9) .
The development of a more rapid and economical bioassay for the scrapie agent in Syrian golden hamsters accelerated purification of the infectious particles (12, 13) . Partial purification led to the discovery that a protein is required for infectivity (14) , in agreement with earlier studies that raised the possibility that protein might b necessary (15) . Procedures that modify nucleic acids did not alter scrapie infectivity (1) . Other investigators found that scrapie infectivity resisted inactivation by both ultraviolet and ionizing radiation (10) ; these results prompted speculation that the scrapie pathogen might be devoid of nucleic acid-a postulate dismissed by most scientists. In addition to ultraviolet irradiation, reagents specifically modifying or damaging nucleic acids, such as nucleases, psoralens, hydroxylamine, and Zn2+ ions, do not alter scrapie infectivity in homogenates (1), microsomal fractions (1), purified prion rod preparations, or detergent-lipid-protein complexes (16, i7) .
On the basis of these findings, I introduced the term "prion" to distinguish the proteinaceous infectious particles that cause scrapie, CJD, GSS, and kuru from both viroids and viruses (1) . Hypotheses for the structure of the infectious prion particle included the following: (i) proteins surrounding a nucleic acid that encodes the proteins (a virus), (ii) proteins associated with a small polynucleotide, and (iii) proteins devoid of nucleic acid. Mechanisms postulated for the replication of infectious prion particles included those used by viruses, the synthesis of polypeptides in the absence of nucleic acid template, and posttranslational modifications of cellular proteins. Subsequent discoveries have narrowed hypotheses for both prion structure and the mechanism of replication. removed during biosynthesis XX CHO CHO GPI (20, 23) . The NH2-terminal re-B || | gion contains five Gly-Pro-rich L L ?
(G-P) octarepeats and two S-Shexarepeats; between codons CHO CHO GPI 96 and 112 a domain control-C ling PrP topology is designated 'S Sas the stop-transfer effector (STE) (52) ; codons 113 to 135 encode a transmembrane (TM) a-helix; codons 157 to 177 encode an amphipathic helix (AH) (52) ; and codons 232 to 254 encode a hydrophobic signal sequence (SS) that is removed when a GPI anchor is added (24) . (B) Unknown modifications (X) of the arginine residues at codons 25 and 37 in PrPSc and at least codon 25 in PrPc result in a loss of the arginine signal in the Edman degradation, but these modifications are inconsistently reported (23) . Both PrP isoforms contain a disulfide (S-S) bond between Cys'79 and Cys214 (23) ; asparagine-linked glycosylation (CHO) occurs at residues 181 and 197 (25) , and a GPI anchor is aitached to Ser23 (24) . (C) PrP 27-30. This molecule is derived from PrPSc by limited proteolysis that removes the NH2-terminal 67 amino acids and leaves a protease-resistant core of 141 amino acids (20, 21) .
Discovery of the Prion Protein
Progress in the study of prions and the degenerative diseases of the CNS that they cause was accelerated by the discovery of a protein designated prion protein (PrP) (18) . In subcellular fractions from hamster (Ha) brain enriched for scrapie infectivity, a proteaseresistant protein of 27 to 30 kD, designated PrP 27-30, was identified; it was absent from controls. Purification of PrP-27-30 to homogeneity allowed determination of its NH2-terminal amino acid sequence (19) , which in turn permitted the synthesis of isocoding mixtures of oligonucleotides that researchers used to identify PrP complementary DNA (cDNA) clones (20, 21) . PrP is encoded by a chromosomal gerne and not by a nucleic acid in the infectious scrapie prion particle (20) . Levels of PrP messenger RNA (mRNA) remain unchanged throughout the course of scrapie infection-an observation that led to the identification of the normal PrP gene product, a protein of 33 to 35 kD, designated PrPc (20) . PrPC is protease-sensitive, whereas PrP 27-30 is the protease-resistant core of a 33-to 35-kD disease-specific protein, designated PrPSc.
Sequencing of molecular clones recovered from cDNA libraries that had been constructed from mRNA isolated from scrapieinfected Syrian Ha and mouse (Mo) brains showed that the Ha and MoPrP cDNAs encode proteins of 254 amino acids ( Fig. 1) (20, 21) . Identical sequences were deduced from genomic clones derived from DNA of uninfected, control animals (20) . Human PrP consists of 253 amino acids (22) . Signal peptides (SPs) of 22 amino acids at the NH2-terminus are cleaved during the biosynthesis of Ha and MoPrPs in the rough endoplasmic reticulum (23) . Twenty-three amino acids are removed from COOH-terminus of HaPrP on addition of a glycoinositol phospholipid (GPI) anchor (24) . Two asparagine-linked oligosaccharides are attached to sites in a loop formed by a disulfide bond (23, 25) . Limited proteolysis of PrPSc removes -67 amino acids from its NH2-terminus to produce 20) . Neither gas-phase sequencing nor mass spectrometric analysis of PrP 27-30 have revealed any amino acid differences between the sequences thus determined and that deduced from the translated sequence of molecular clones (26) . The covalent structure of PrPSc remains uncertain because purified fractions contain -i05 PrP 27-30 molecules per ID50 unit (18) . (One ID50 unit is the infectious dose at which 50% of the animals develop scrapie.) If < 1% of the PrPSc molecules contained an amino acid substitution or posttranslational modification that conferred scrapie infectivity, our methods would not detect such a change (27) .
Infectious Prion Particles
Information on PrPSc in prion diseases indicates that prions are composed of PrPSC molecules (Table 1) . Although some investigators contend that PrPSc is merely a pathologic product of scrapie infection aifd that PrPSC coincidentally purifies with the "scrapie virus" (28) , there are few data to support this view. No infective fractions containing <1 PrPSC molecule per ID50 unit have been found; such a result would indicate that PrPSc is not required for infectivity. Some investigators report that PrPSc accumulation in hamsters occurs after the synthesis of many infective units (29) , but these results have been refuted (30) . The discrepancy appears to be due to comparisons of infectivity in crude homogenates with PrPSc concentrations measured in purified fractions.
The search for a component in the prion particle other than PrP has focused on a nucleic acid because the existence of such a component would readily explain different isolates or strains of infectivity (31) . Specific scrapie isolates characterized by distinct incubation times retain this property when repeatedly passaged in mice or hamsters (31) . Other factors modulating scrapie incubation times include PrP gene expression, murine genes linked to PrP (Prn-i and Sinc), dose of inoculum, route of inoculation, and the genetic origin of the prion inoculum. A scrapie-specific nucleic acid has not been found with reagents that modify or hydrolyze polynucleotides, with molecular cloning procedures, or with physicochemical techniques (16, 17, 32) . Although available data do not permit exclusion of a scrapie-specific polynucleotide (27) , its existence seems unlikely. That prions might contain noncovalently bound cofactors, such as peptides, oligosaccharides, fatty acids, sterols, or inorganic compounds, deserves consideration. (18, 23) .
2) Kinetics of proteolytic digestion of PrP 27-30 and infectivity are similar (18) .
3) Copurification of PrPSc and infectivity by immunoaffinity chromatography. a-PrP antisera neutralization of infectivity (38). 4) PrPSC detected only in clones of cultured cells producing infectivity (50a). 5) PrP amyloid plaques are specific for prion diseases of animals and humans (34) . Deposition of PrP amyloid is controlled, at least in part, by the PrP sequence (71).
6) Correlation between PrPSc (or PrPCJD) in brain tissue and prion diseases in animals and humans (82). 7) Genetic linkage between MoPrP gene and scrapie incubation times (55, 56) . PrP gene of mice with long incubation times encodes amino acid substitutions at codons 108 and 189, as compared to mice with short or intermediate incubation times (41) . 8) Syrian HaPrP transgene and scrapie PrPSc in the inoculum govern the "species barrier," scrapie incubation times, neuropathology, and prion synthesis in mice (71, 72) . 9) Genetic linkage between human PrP gene mutation at codon 102 and development of GSS (3) . Association between codon 200 point mutation or codon 53 insertion of six additional octarepeats and familial CJD (4, 62) . 10) Mice expressing MoPrP transgenes with the point mutation of GSS spontaneously develop neurologic dysfunction, spongiform brain degeneration, and astrocytic gliosis (61) .
PrP Polymers and Amyloid
The discovery of PrP 27-30 in fractions enriched for scrapie infectivity was accompanied by the identification of rod-shaped particles (18, 33) . The rods are ultrastructurally indistinguishable from many purified amyloids and display the tinctorial properties of amyloids (33) . These findings were followed by the demonstration that amyloid plaques in prion diseases contain PrP, as determined by immunoreactivity and amino acid sequencing (34) . Some investigators -believe that scrapie-associated fibrils are synonymous with the prion rods and are composed of PrP, even though these fibrils can be distinguished ultrastructurally and tinctorially from amyloid polymers (35, 36) .
The formation of prion rods requires limited proteolysis in the presence of detergent (37) . Thus, the prion rods in fractions enriched for scrapie infectivity are largely, if not entirely, artifacts of the purification protocol. Solubilization of PrP 27-30 into liposomes with a retention of infectivity (17) demonstrated that large PrP polymers are not required for infectivity and pennitted the copurification of PrPSc and infectivity by immunoaffinity chromatography (38) .
PrP Gene Structure and Expression
Localization of PrP genes to the short arm of human chromosome 20 and the -homologous region of Mo chromosome 2 suggests that PrP genes existed before the speciation of mammals (39) . Hybridization studies demonstrated <0.004 PrP gene sequences per ID50 unit in purified prion fractions, indicating that the gene encoding PrPSc is not a component of the infectious prion particle (20) . This feature distinguishes prions from viruses, including those retroviruses that carry cellular oncogenes, and from satellite viruses that derive their coat proteins from other viruses that had previously infected plant cells.
The entire open reading frame of PrP genes is contained in a single exon, eliminating the possibility that variant forms of PrP arise from alternative RNA splicing (20, 40, 41) , but not excluding such mechanisms as RNA editing or protein splicing (42) . The two exons of the HaPrP gene are separated by a 10-kb intron: exon 1 encodes a portion of the 5' untranslated leader sequence, whereas exon 2 encodes PrP and the 3' untranslated region (20) . The MoPrP gene is composed of three exons, with exon 3 analogous to exon 2 of the Ha gene (40) . The promoters of both the Ha and MoPrP genes contain copies of G-C-rich nonamers that may function as a canonical binding site for the transcription factor Spl (43) .
Although PrP mRNA is constitutively expressed in the brains of adult animals (20) , it is regulated during development. In the septum, PrP mRNA and choline acetyl transferase were found to increase in parallel during development (44) . In other brain regions, PrP gene expression occurred at an earlier age. The highest concentrations of PrP mRNA are found in neurons (45) . (Fig. 2) (20-22, 46, 47) . Although the function of PrPC is unknown, the MoPrP sequence is -30% identical with a molecule found in fractions enriched for the acetylcholine receptor-inducing activity in chickens (48) .
Synthesis of PrP Isoforms
Pulse-chase experiments with scrapie-infected cultured cells indicate that conversion of prpC is a posttranslational event (49) .
Although the synthesis and degradation Of PrPC are rapid (49, 50) , (46) . Mice with Prnpb genes have long scrapie incubation times and amino acid substitutions at codons 108 (Leu -* P and 189 (Thr -* Val) (41) 
. (C) Human PrP mutations and polymorphis
Octarepeat inserts of 32, 48, 56 , and 72 amino acids have been found (60, 62) . Inserts of 48, 56, and 72 amino acids are associated with familial CJD.
Point mutations at codons 102 (Pro -* Leu), 117 (Ala -* Val), and 198 (Phe -* Ser) are found in patients with GSS (3, 60, 66) . There are common polymorphisms at codons 117 (Ala Ala) and 129 (Met Val) (66, 83) . Point mutation at codons 178 (Asp Asn) and 200 (Glu Lys) are found in patients with familial CJD (4, 64, 66) . Single letter code for amino acids is as follows: A, Ala; D, Asp; E, Glu; F, Phe; K, Lys; L, Leu; M, Met; N, Asn; P, Pro; Q, Gin; R, Arg; S, Ser; T, Thr; and V, Val.
the accumulation of PrPSc is slow and confined to the chase period (Table 2 ) (49). These observations are in accord with studies that show that PrPSc accumulates in the brains of scrapie-infected animals, yet PrP mRNA concentrations remain unchanged (20) .
Both PrP isoforms transit through the Golgi apparatus, where their asparagine-linked oligosaccharides are modified and sialic acid is added (25) . PrPc is presumably transported in secretory vesicles to the external cell surface, where it is anchored by a GPI moiety (24) . In contrast, PrPSc accumulates in cells, where it is deposited in cytoplasmic vesicles, many of which appear to be secondary lysosomes (50a) . Much of the mass added to PrPSc during posttranslational modification is due to asparagine-linked oligosaccharides, but they are not required for the synthesis of (71) ,ug/g ,ug/g Presence in purified prions (18, 19, -+* 33) Protease resistance (18-20, 33) -+t Presence in amyloid rods (33, 34, - Two forms of PrP are found in cell-free translation studies: a transmembrane form that spans the bilayer twice (at the transmembrane and amphipathic helix domains) and a secretory form (Fig. 1)  (52) . The stop-transfer effector domain controls the topogenesis of PrP. That PrP contains a transmembrane domain as well as a GPI anchor poses a topologic conundrum. It seems likely that membrane-dependent events feature in the synthesis of PrPSC, especially because brefeldin A, which selectively destroys the Golgi stacks, prevents PrPSC synthesis in scrapie-infected cultured cells (53) . The association of scrapie infectivity with membrane fractions has been appreciated for many years (11); hydrophobic interactions are thought to be responsible for the insolubility of infectious prion particles and for many of the difficulties encountered during attempts to characterize the particles (13, 17, 54) .
Genetic Linkage of PrP with Scrapie Incubation Times
Studies of PrP genes (Prn-p) in mice with short and long scrapie incubation times demonstrated genetic linkage between a Prn-p restriction fragment length polymorphism (RFLP) and genes (Prn-i and Sinc) that modulate the incubation times of the disease (55) (56) (57) . It remains to be established whether Prn-p, Prn-i, and Sinc are all allelic. The PrP sequences of NZW (Prn-pa) and I/Ln (Prn-pb) mice with short and long scrapie incubation times, respectively, differ at codons 108 and 189 ( Fig. 2) (41) . Although these amino acid substitutions suggest a congruency of Prn-p and Prn-i, experiments with Prn_pa mice expressing Prn-pb transgenes demonstrated a paradoxical shortening of incubation times (40) , instead of the prolongation predicted from (Prn-pa x Prn-pb) Fl mice (long incubation times are dominant) (55) (56) (57) . It is unknown whether this paradoxical shortening in transgenic (Prn_pb) mice results from high levels of PrPc expression.
Host genes also influence the development of scrapie in sheep.
Parry argued that natural scrapie is a genetic disease that could be eradicated by proper breeding protocols (7) . He considered its transmission by inoculation of importance primarily for laboratory studies and the communicable infection of little consequence in nature. Other investigators viewed natural scrapie as an infectious disease and argued that a host's genes modulate susceptibility to an endemic infectious agent (58) . The dominant incubation time gene (Sip) for experimental scrapie in Cheviot sheep is thought to be linked to a PrP gene RFLP (59), a situation analogous to that for Prn-i and Sinc in mice. However, the data for genetic linkage in sheep are not convincing and further studies are needed, especially in view of earlier investigations in which susceptibility of sheep to scrapie was thought to be governed by a recessive gene (7) . In Suffolk sheep, a polymorphism in PrP was found at codon 171 ( Fig.  2B) (46) ; whether this polymorphism segregates with a Sip phenotype in Cheviot sheep is uncertain.
Human Familial Prion Diseases
CJD was believed to have a genetic basis when it was recognized that -10% of CJD cases are familial (2) . The discovery of the PrP gene (PRNP) in humans (22, 39) raised the possibility that mutation might feature in the human prion diseases; a point mutation at PrP codon 102 was found to be genetically linked to GSS syndrome (Fig. 2C) (3) . The codon 102 mutation has been found in American, British, German, Japanese, Canadian, Israeli, French, and Italian families, as well as in the Austrian family in which GSS was first described; these results suggest that the mutation may have arisen independently multiple times (60) .
When the codon 102 point mutation was introduced into MoPrP in transgenic mice, spontaneous CNS degeneration occurred, characterized by clinical signs indistinguishable from experimental murine scrapie and neuropathology consisting of widespread spongiform morphology and astrocytic gliosis (61) . By inference, these results suggest that PrP mutations cause GSS and familial CJD. It is unclear whether low levels of protease-resistant PrP in the brains of transgenic mice with the GSS mutation is PrPSc or residual PrPC. Undetectable or low levels of PrPSc in the brains of these transgenic mice are consistent with the results of transmission experiments that suggest low titers of infectious prions. If brain extracts transmit CNS degeneration to inoculated recipients and the de novo synthesis of prions can be demonstrated by serial passage, then such observations would indicate that prions are devoid of foreign nucleic acid, in accord with studies that use other experimental approaches (10, 16, 28, 32 ).
An insert of 144 bp at codon 53 with six additional octarepeats has been described in individuals with CJD from four families that reside in southern England (Fig. 2C ) (62); normal individuals have five octarepeats. Genealogical investigations have shown that all four families are related, suggesting that there was a single founder born more than two centuries ago. Seven or nine octarepeats (in addition to the normal five) were found in individuals with CJD, whereas deletion of one octarepeat or four additional octarepeats have been identified in individuals without the neurologic disease (62) .
For many years the high incidence of CJD among Israeli Jews of Libyan origin was thought to be caused by the consumption of lightly cooked sheep brain or eyeballs (63) . However, some Libyan and Tunisian Jews in families with CJD have a PrP gene point mutation at codon 200 (4, 64) . One patient was homozygous for the mutation, but her clinical presentation was similar to that of heterozygotes (4); therefore, familial prion diseases are true autosomal dominant disorders like Huntington's disease (65) . The codon 200 mutation also occurs in Slovaks originating from Orava in north central Czechoslovakia (60) .
Other point mutations at codons 117, 178, and 198 also segregate with inherited prion diseases (66) . Some patients once thought to have familial Alzheimer's disease are now known to have prion diseases on the basis of PrP immunostaining of amyloid plaques and PrP gene mutations (67) . Patients with the codon 198 mutation have numerous neurofibrillary tangles that stain with antibodies to X and have amyloid plaques (67) that are composed largely of a PrP fragment extending from residues 58 to 150 (68) .
It has been suggested that PrP gene mutations render individuals susceptible to a virus (36) . The putative scrapie virus is.thought to persist in a worldwide reservoir of humans, animals, or insects without causing detectable illness. Yet one in 106 individuals develop sporadic CJD and die from a lethal infection, whereas -100% of people with PrP point mutations or inserts eventually develop neurologic dysfunction. That PrP gene germline mutations in patients and at-risk individuals cause familial prion diseases is supported by the experiments with transgenic mice described above. The transgenic mouse studies also suggest that sporadic CJD arises from the spontaneous conversion of prpC to PrPCJD (a component of the prion that causes CJD) due either to a PrP gene somatic mutation or to a rare event involving modification of wild-type PrPC. 1518 SCIEENCE, VOL.
Transgenic Animals and Species Barriers
The species barrier was discovered when scrapie prions were passaged between species; this is a stochastic process characterized by prolonged incubation times (69) . Prions synthesized de novo reflect the sequence of the host PrP gene and not that of the PrPSc molecules in the inoculum (70) . On subsequent passage in a homologous host, the incubation time shortens to a constant length that is observed for all subsequent passages, and transmission becomes a nonstochastic process. The species barrier is of practical importance in assessing the risk for humans of acquiring CJD after consumption of scrapie-infected lamb or BSE-infected beef.
To test the hypothesis that differences in PrP gene sequences might be responsible for the species barrier, we constructed transgenic mice expressing HaPrP (71, 72) . The PrP genes of Syrian hamsters and mice encode proteins differing at 14 residues. Incubation times in four lines of transgenic mice inoculated with Mo scrapie prions were prolonged, as compared to those observed for nontransgenic, control mice (Fig. 3A) . Transgenic mice inoculated with Ha prions showed abbreviated incubation times in a nonstochastic process (Fig. 3B) (71, 72) . The length of the incubation time after inoculation with Ha prions was inversely proportional to the level of HaPrPC in the brains of the transgenic mice (Fig. 3 , B and C) (71) . HaPrPSC concentrations in the brains of clinically ill mice were similar in all four transgenic lines inoculated with Ha prions (Fig. 3D) . Bioassays of brain extracts from clinically ill transgenic mice inoculated with Mo prions revealed that only Mo prions but no Ha prions were produced (Fig. 3E) . Conversely, inoculation of transgenic mice with Ha prions led only to the synthesis of Ha prions (Fig. 3F) . Thus, the de novo synthesis of prions in transgenic mice is species specific and reflects the genetic origin of the inoculated prions. Similarly, the neuropathology of transgenic mice is determined by the genetic origin of prion inoculum. Mo prions injected into transgenic mice produced neuropathology characteristic of mice with scrapie. A moderate degree of vacuolation in both the gray and white matter was found, whereas amyloid plaques were rarely detected (Fig. 3G) . Inoculation of transgemnc mice with Ha prions produced vacuolation of the gray matter, no vacuolation of Fig. 3 . Transgenic mice expressing Syrian Ha prion protein exhibit speciesspecific scrapie incubation times, infectious prion synthesis, and neuropathology (71) . The number of mice used in each trial and the mean + SEM values can be found in (71) the white matter, and numerous HaPrP amyloid plaques, characteristic of Syrian hamsters with scrapie (Fig. 3H) .
These studies with transgenic mice establish that the PrP gene influences all aspects of scrapie, including the species barrier, the replication of prions, the incubation times, the synthesis of PrP&, and the neuropathologic changes.
Prion Multiplication
The mechanism by which prion infectivity increases is unknow Some investigators believe that a scrapie-specific polynucleotide drives prion replication (28, 29, 31) . If prions contain a scrapiespecific nucleic acid, then such a molecule would be expected to direct the multiplication of the scrapie agent by a stragety similar to that used by viruses (Fig. 4A) . In the absence of any chemical or physical evidence for a scrapie-specific polynucleotide (16, 28, 32) , it seems reasonable to consider alternative mechanisms that might be responsible for prion biosynthesis. The multiplication of prion infectivity is an exponential process in which the posttranslational conversion of PrPC or a precursor to PrPSC appears to be obligatory (49) . A PrPSc molecule might combine with a PrPC molecule to produce a heterodimer that is subsequently transformed into two PrPSc molecules (Fig. 4B ). In the next cycle, two PrP& molecules combine with two PrPC molecules, giving rise to four PrP& molecules that combine with four PrPC molecules, creating an A E 500.
.0400-6 E 300-jIi f . PrP transgenes show that the mice produce only those prions present in the inoculum (Fig. 3, E and F) (71) . Presumably, PrPSc in ihe prion inoculum interacts with the homologous PrPG substrate during replication to produce more of the same prions (Fig. 4C ).
In the absence of any candidate posttranslational chemical modifications (26) that differentiate PrPc from PrPSc, we must consider the possibility that conformation distinguishes these isoforms. Various isolates of scrapie prions (31) might result from multiple conformers that could act as templates for the folding of de novo synthesized PrPSC molecules during prion replication (Fig. 4D ).
Although this proposal is unorthodox, it is consistent with observations from transgenic mice studies that indicate that PrPSc in the inoculum binds to homologous PrPc or a precursor to form a heterodimeric intermediate in the replication process (71) . Presumably, "foldases," chaperones, or other macromolecules (73) feature in the conversion of the PrPc-PrPsc heterodimer to PrPSc molecules.
The number of PrPSc molecules composing a prion particle is unknown, but ionizing radiation studies indicate a target size of 55 kD, suggesting that a PrPSc dimer or possibly trimer is required for infectivity (74) . (Fig. 3C ). In Tg(HaPrP)7 mice, the Sc237 isolate produced incubation times of 48 ? 1 day (n = 26), whereas 139H gave incubation times of 40 ? 3 day (n = 11) (75) .
One interpretation of these observations is that Sc237 prions have a higher affinity for PrPc than 139H prions that is only apparent at nonsaturating levels of substrate. Increased levels of PrPc substrate in Tg(HaPrP)7 mice might saturate the PrPSc conversion process, thus resulting in a diminution of the incubation times for both prion isolates and eliminating the differences between them. In Chinese and Armenian hamsters with PrP gene sequences that differ from that of the Syrian at 7 and 8 codons, respectively (47), 139H
produces incubation times that are either shorter or similar to those observed with Sc237. In this case, the amino acid sequence of PrP may modulate the affinities of PrPSC in the two isolates for PrPc molecules; indeed, the formation of PrPc-PrPsc heterodimers may be the rate-limiting step in the prion biosynthesis that determines scrapie incubation times (Fig. 4D ).
In humans carrying point mutations or inserts in their PrP genes, mutant PrPc molecules might spontaneously convert into PrPSc (Fig. 4E) . Although the initial stochastic event may be inefficient, once it happens the process would then become autocatalytic. The proposed mechanism explains the existence of individuals harboring germline mutations who do not develop CNS dysfunction for decades and is also consistent with results with transgenic mice that express the GSS mutation and spontaneously develop CNS degeneration (61) . Whether all GSS and familial CJD cases are attributable to infectious prions or whether some represent inborn errors of PrP metabolism in which neither PrPSC nor prion infectivity accumulates is unknown.
Conformational changes in allosteric enzymes induced by phosphorylation or the binding of small ligands (76) might provide some precedent for the proposed models (Fig. 4, B through E) . Consider the possibility that PrPSC acts as a ligand that induces a conformational change in PrPG to produce a second PrPSC molecule. Noteworthy are five different crystalline allomorphs of mutant lysozyme from bacteriophage T4 (77) ; these are thought to represent a continuous range of conformations that occur in solution. Rapidand slow-folding populations of lysozyme have been observed; the latter are presumed to have arisen from cis-trans isomerization of peptide bonds preceding proline residues (78) . Whether cis-trans proline isomerization is of significance in the conversion of PrPG or a precursor to PrPSc is uncertain. Of interest are the folding and assembly of phage tail spike proteins into trimers that resist denaturation and proteolysis, properties remiscent of those exhibited by PrPSc (79) . In ciliates, the cytoplasmic inheritance of asymmetrical arrangements of surface structures (80) may also provide some insight into the mechanism by which PrPG is converted to PrPSc during the propagation of distinct scrapie isolates.
Although results with transgenic mice argue for the interaction of PrPSc with PrPG during scrapie prion multiplication, there are no data to support the proposal that prion multiplication proceeds through a crystallization process involving PrP amyloid formation (81) . The absence or rarity of amyloid plaques in many prion diseases, as well as the inability to identify any amyloid-like polymer in cultured cells that synthesize prions, does not support this hypothesis (37, 71) . Purified infectious preparations isolated from scrapie-infected Ha brains contain PrPSc molecules that exist as amorphous aggregates; only if PrPSc is exposed to detergents and limited proteolysis does it polymerize into prion rods with the ultrastructural and tinctorial features of amyloid (37) . Furthermore, infectious prions are produced (dashed lines), then they stimulate the synthesis of more PrPCJD in humans and PrPSc in experimental animals.
Alternatively, prion infectivity is not generated, but the host develops neurologic dysfunction, spongiform degeneration, astrocyiic gliosis, and possibly PrP amyloid plaques (2, 3, 60, 61) .
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dispersion of prion rods into liposomes results in a 10-to 100-fold increase in scrapie prion titer; no rods could be identified in these fractions by electron microscopy (17) .
Future Challenges and New Approaches
Whether prions are composed entirely of PrPSC molecules or contain a second component needs to be resolved. Determining the crystal structures of PrPC and PrPSC, as well as the structures of these molecules in solution, is important. Understanding the molecular events that feature in prion replication should help decipher the structural basis for the scrapie isolates or strains that have different incubation times in the same host. Whether distinct conformations of PrPSc correspond to different prion isolates is unknown. Elucidating the function of PrPC might extend our understanding of the pathogenesis of prion diseases and point to other macromolecules that participate in a variety of human and animal diseases of unknown etiology. Lessons learned from prion diseases may give insights into the etiologies, as well as the pathogenic mechanisms, of such common CNS degenerative disorders as Alzheimer's disease, amyotrophic lateral sclerosis, and Parkinson's disease.
The lack of effective therapies for the prion diseases, all of which are fatal, poses a significant challenge. Because the mechanism of prion replication appears unprecedented, it is not surprising that antibacterial, fungal, and viral therapeutics are of little value in the modification of the course of prion diseases. On the other hand, prenatal testing in families with prion diseases does present a method for controlling the genetic spread of these disorders.
Although the results of many studies indicate that prions are a new class of pathogens distinct from both viroids and viruses, it is unknown whether different types of prions exist. Are there prions that contain modified proteins other than PrPSc? Assessing how widespread prions are in nature and defining their subdasses are subjects for future investigation. Elucidation of the mechanism by which brain cells cease to function and die in prion diseases after a long delay may offer approaches to understanding how neurons develop, mature, and continue to transmit signals for decades.
